Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Penningtons Manches Cooper is an active UK and international law firm, not a biotech, pharma, or healthcare operating company. The firm provides legal services across corporate, commercial, disputes, real estate, private client, and sector-focused practices, including a dedicated life sciences practice that advises biotech, pharmaceutical, medtech, laboratory services, contract research, and research organizations. Its life sciences work centers on legal advisory services such as financings, mergers and acquisitions, IPOs, commercial contracts, manufacturing arrangements, clinical trials, intellectual property, and market access issues. The firm operates from multiple offices in the UK and internationally and is led by chief executive officer Helen Drayton. For a biotech analyst, the key point is that this is a sector-specialist legal adviser to healthcare and life sciences clients rather than a drug developer or healthcare products company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Penningtons Manches Cooper.